New Drug's first human test paves way for future cancer and infection research
NCT ID NCT07450833
Summary
This was a first-in-human study to check the safety and how the body processes a new drug called Benfo-Oxythiamine (B-OT). The study involved 48 healthy male volunteers who took the drug as a capsule and were closely monitored. The goal was to gather basic safety data to see if the drug could be studied further for potential use against diseases like cancer and infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Diagnostics and Consultation Center (DCC) Convex EOOD
Sofia, Bulgaria
Conditions
Explore the condition pages connected to this study.